European Companies Search Engine
EU funding (€3,971,348): Molecular Tools for Nucleic Acid Manipulation for Biological Intervention Hor26 Sept 2016 EU Research and Innovation programme "Horizon"
Overview
Text
Molecular Tools for Nucleic Acid Manipulation for Biological Intervention
MMbio will bridge the classically separate disciplines of Chemistry and Biology by assembling leading experts from academia and non-academic partners (industry, technology transfer & science communication) to bring about systems designed to interfere therapeutically with gene expression in living cells. Expertise in nucleic acid synthesis, its molecular recognition and chemical reactivity is combined with drug delivery, cellular biology and experimental medicine. This project represents a concerted effort to make use of a basic and quantitative understanding of chemical interactions to develop and deliver oligonucleotide molecules of utility for therapy. Our chemical biology approach to this field is ambitious in its breadth and represents a unqiues opportunity to educate young scientists across sectorial and disciplinary barriers. Training will naturally encompass a wide range of skills, requiring a joint effort of chemists and biologists to introduce young researchers in a structured way to and array of research methodologies that no single research grouping could provide. The incorporation of early-stage and later stag ebiotechnology enterprises ensures that commercialisation of methodologies as well as the drug development process is covered in this ITN. We hope that MMBio will train scientists able to understand both the biological problem and the chemistry that holds the possible solution and develop original experimental approaches to stimulate European academic and commercial success in this area.
Funded Companies:
| Company name | Funding amount |
| Alzheimer's Society | ? |
| Astrazeneca AB | €263,659 |
| JOHANN WOLFGANG GOETHE-UNIVERSITAET FRANKFURT AM MAIN | €249,216 |
| Karolinska Institutet | €263,659 |
| Medimmune Ltd. | €273,288 |
| Region Stockholm | €263,659 |
| Rise Research Institutes OF Sweden AB | €234,364 |
| SP Process Development AB | €29,295 |
| The Chancellor Masters and Scholars of the University of Cambridge | €546,576 |
| The University of Sheffield | €546,576 |
| TURUN YLIOPISTO | €269,145 |
| Universita Degli Studi Di Padova | €516,123 |
| UNIVERSITAET BERN | €265,227 |
| Universiteit Gent | €250,560 |
Source: https://cordis.europa.eu/project/id/721613
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Alzheimer's Society, London.
The visualizations for "Alzheimer's Society - EU funding (€3,971,348): Molecular Tools for Nucleic Acid Manipulation for Biological Intervention"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
